Compare FDC LTD. with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. SANOFI INDIA FDC LTD./
SANOFI INDIA
 
P/E (TTM) x 16.2 36.1 44.8% View Chart
P/BV x 2.2 6.3 34.6% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 FDC LTD.   SANOFI INDIA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
SANOFI INDIA
Dec-18
FDC LTD./
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3196,840 4.7%   
Low Rs1644,630 3.5%   
Sales per share (Unadj.) Rs61.61,203.1 5.1%  
Earnings per share (Unadj.) Rs9.9165.3 6.0%  
Cash flow per share (Unadj.) Rs12.0209.9 5.7%  
Dividends per share (Unadj.) Rs084.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs73.2963.6 7.6%  
Shares outstanding (eoy) m174.4023.03 757.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.94.8 82.2%   
Avg P/E ratio x24.334.7 69.9%  
P/CF ratio (eoy) x20.227.3 73.9%  
Price / Book Value ratio x3.36.0 55.5%  
Dividend payout %050.8 0.0%   
Avg Mkt Cap Rs m42,118132,078 31.9%   
No. of employees `0005.53.3 167.6%   
Total wages/salary Rs m2,1674,068 53.3%   
Avg. sales/employee Rs Th1,943.78,393.8 23.2%   
Avg. wages/employee Rs Th391.71,232.4 31.8%   
Avg. net profit/employee Rs Th313.71,153.0 27.2%   
INCOME DATA
Net Sales Rs m10,75127,708 38.8%  
Other income Rs m510897 56.8%   
Total revenues Rs m11,26028,605 39.4%   
Gross profit Rs m2,2676,235 36.4%  
Depreciation Rs m3511,027 34.2%   
Interest Rs m147 200.0%   
Profit before tax Rs m2,4116,098 39.5%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6712,292 29.3%   
Profit after tax Rs m1,7353,806 45.6%  
Gross profit margin %21.122.5 93.7%  
Effective tax rate %27.837.6 74.1%   
Net profit margin %16.113.7 117.5%  
BALANCE SHEET DATA
Current assets Rs m7,21315,922 45.3%   
Current liabilities Rs m2,1046,235 33.7%   
Net working cap to sales %47.535.0 135.9%  
Current ratio x3.42.6 134.3%  
Inventory Days Days5464 85.6%  
Debtors Days Days2821 132.9%  
Net fixed assets Rs m6,8657,539 91.1%   
Share capital Rs m175230 76.2%   
"Free" reserves Rs m12,58621,962 57.3%   
Net worth Rs m12,76122,192 57.5%   
Long term debt Rs m60-   
Total assets Rs m15,04129,839 50.4%  
Interest coverage x173.2872.1 19.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 77.0%   
Return on assets %11.612.8 91.0%  
Return on equity %13.617.2 79.3%  
Return on capital %19.027.5 68.9%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,8897,587 24.9%   
Fx outflow Rs m07,145 0.0%   
Net fx Rs m1,889442 427.3%   
CASH FLOW
From Operations Rs m1,4983,739 40.1%  
From Investments Rs m201-731 -27.5%  
From Financial Activity Rs m-1,694-1,972 85.9%  
Net Cashflow Rs m101,036 1.0%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 4.7 14.4 32.6%  
FIIs % 7.5 14.6 51.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.5 181.0%  
Shareholders   23,730 15,184 156.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PROCTER & GAMBLE HEALTH  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Realty and Telecom Stocks Drag(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is flat while the Hang Seng is down 0.9%.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 23, 2019 11:23 AM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - GLENMARK PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS